Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS and BRAF mutations in prostate carcinomas of Chinese patients.

Cancer genetics and cytogenetics - 1 Apr 2010

Shen Yanying, Lu Yachao, Yin Xiaolu, Zhu Guanshan, Zhu Jianshan

Abstract excerpt

Aberrance in the RAS/RAF/MEK/MAPK pathway is reportedly important in many tumor types, including prostate carcinoma. Continuous activation of the pathway can be caused by mutations of upstream targets such as KRAS and BRAF. However, rates of KRAS and BRAF mutations in prostate carcinoma are reported to vary in different populations. To date, there has been no such report in Chinese patients. In this study, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Asian People

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Mutation

Share to Polymerase Chain Reaction

Share to Prostatic Neoplasms

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 20303012
DOI: 10.1016/j.cancergencyto.2009.12.003

Genes

KRAS
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS and BRAF mutations in prostate carcinomas of Chinese patients.PMID 20303012Read ↗

BRAF and KRAS mutations in prostatic adenocarcinoma.Semantic proximity Read ↗

Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.Semantic proximity Read ↗

Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations.Semantic proximity Read ↗

Identification of frequent BRAF copy number gain and alterations of RAF genes in chinese prostate cancerSemantic proximity Read ↗

Application of pyrosequencing technique for improved detection of K-Ras mutation in formalin-fixed and paraffin-embedded prostate carcinoma tissues in Chinese patients.Semantic proximity Read ↗

Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.Semantic proximity Read ↗

Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas.Semantic proximity Read ↗

Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric CancersSemantic proximity Read ↗

Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.Semantic proximity Read ↗

Comparison of ras activation in prostate carcinoma in Japanese and American men.Semantic proximity Read ↗

Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinomaSemantic proximity Read ↗

Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.